Skip to main content

W 718 (Venlafaxine Hydrochloride Extended Release 150 mg)

Pill with imprint W 718 is Brown, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended Release 150 mg. It is supplied by Wockhardt USA LLC.

Venlafaxine is used in the treatment of autism; anxiety; generalized anxiety disorder; depression; major depressive disorder and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W 718

Venlafaxine hydrochloride extended release 150 mg W 718

Venlafaxine Hydrochloride Extended Release

Imprint
W 718
Strength
150 mg
Color
Brown
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Wockhardt USA LLC.
Inactive Ingredients
microcrystalline cellulose, D&C Red No. 28, ethylcellulose, FD&C Blue No. 1, FD&C Yellow No. 6, ferrosoferric oxide, gelatin, methacrylic acid - ethyl acrylate copolymer (1:1) type a, povidone k30, silicon dioxide, sodium bicarbonate, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
64679-0718 Wockhardt USA LLC
00904-6248 (Discontinued) Major Pharmaceuticals
63739-0633 McKesson Packaging Services

Get help with Imprint Code FAQs.

Related images for "W 718"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.